Funders › CA › The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders › 2023
Grants paid by The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders, tax year 2023
EIN 27-0179192 · Orange, CA · Form 990, Schedule I · NTEE E24
In tax year 2023, The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (EIN 27-0179192) reported 23 grants paid totaling $7,156,307. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2023
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2023 | Sickle Cell Disease Foundation of California Ontario, CA | A | $3,111,913 + $3,111,913 non-cash | paid | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | The Regents of the University of California (ucsf) San Francisco, CA | A | $1,299,001 + $1,299,001 non-cash | paid | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Loma Linda University Health Care Loma Linda, CA | A | $560,943 + $560,943 non-cash | paid | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Kern Medical Center Foundation Bakersfield, CA | A | $457,891 + $457,891 non-cash | paid | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | The Regents of the University of California (ucsd) San Diego, CA | A | $374,999 + $374,999 non-cash | paid | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | The Regents of the University of California (davis) Sacramento, CA | A | $274,434 + $274,434 non-cash | paid | SUBCONTRACT HRSA & CDPH GRANTS SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | The Regents of the University of California (ucla) Los Angeles, CA | A | $220,037 + $220,037 non-cash | paid | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Valley Children's Hospital of Central California Madrea, CA | A | $130,309 + $130,309 non-cash | paid | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM | 202402279349300035 |
| 2023 | Hemostasis and Thrombosis Center of Nv Las Vegas, NV | A | $96,921 + $96,921 non-cash | paid | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM | 202402279349300035 |
| 2023 | Children's Hospital Los Angeles Los Angeles, CA | A | $89,497 + $89,497 non-cash | paid | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM | 202402279349300035 |
| 2023 | Lucile Packard Children's Hospital at Stanford Palo Alto, CA | A | $85,194 + $85,194 non-cash | paid | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM | 202402279349300035 |
| 2023 | Rady Children's Hospital - San Diego San Diego, CA | A | $56,817 + $56,817 non-cash | paid | SUBCONTRACT CDC/ATHN GRANT PUBLIC HEALTH SURVEILLANCE | 202402279349300035 |
| 2023 | Phoenix Children's Hospital Phoenix, AZ | A | $54,308 + $54,308 non-cash | paid | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Los Angeles Orthopaedic Hospital Los Angeles, CA | A | $53,923 + $53,923 non-cash | paid | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM | 202402279349300035 |
| 2023 | University of Colorado Aurora, CO | A | $46,360 + $46,360 non-cash | paid | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Oregon Health and Science University Portland, OR | A | $45,769 + $45,769 non-cash | paid | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Kapi'olani Medical Center for Women and Children Honolulu, HI | A | $41,004 + $41,004 non-cash | paid | SUBCONTRACT HRSA GRANT HEMOPHILIA REGIONAL COMPREHENSIVE CARE PROGRAM | 202402279349300035 |
| 2023 | Ihc Health Services Inc Salt Lake City, UT | A | $33,732 + $33,732 non-cash | paid | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | The University of Arizona Tucson, AZ | A | $33,413 + $33,413 non-cash | paid | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Seattle Children's Hospital Seattle, WA | A | $29,786 + $29,786 non-cash | paid | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Torrance, CA | A | $28,367 + $28,367 non-cash | paid | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | Arrowhead Regional Medical Center Colton, CA | A | $26,689 + $26,689 non-cash | paid | SUBCONTRACT CDPH GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
| 2023 | John Hopkins University Baltimore, MD | A | $5,000 + $5,000 non-cash | paid | SUBCONTRACT HRSA GRANT SICKLE CELL TREATMENT DEMONSTRATION PROGRAM | 202402279349300035 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.